期刊文献+

组织因子途径抑制物-2和趋化因子受体-4在非小细胞肺癌组织中的表达及临床意义 被引量:1

Clinical significance of TFPI-2 and CXCR4 expression in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨非小细胞肺癌(NSCLC)组织中组织因子途径抑制物-2(TFPI-2)和趋化因子受体-4(CXCR4)蛋白表达与临床病理特征及预后的关系。方法应用免疫组织化学方法检测60例NSCLC癌组织及癌旁组织及10例正常组织中的TFPI-2及CXCR4,并分析TFPI-2和CXCR4的表达水平与性别、年龄、组织类型、分化程度、TNM分期及淋巴结转移的关系。结果 TFPI-2在NSCLC组织中的表达水平明显低于癌旁组织和正常组织,CXCR4表达水平在癌组织中明显高于癌旁组织和正常组织(P<0.05)。TFPI-2和CXCR4表达与性别、年龄、组织类型、分化程度、TNM分期无关,仅仅与淋巴结转移有关(P<0.05)。TFPI-2和CXCR4在NSCLC组织中呈现负相关(r=-0.26,P<0.05)。结论 TFPI-2可能通过抑制增高的CXCR4表达来影响肿瘤的迁徙转移。 Objective To explore the expression of tissue factor way inhibitor-2 (TFPI-2 )and chemokine receptor-4 (CXCR4)protein,clinical pathological characteristics and prognosis in the non-small cell lung cancer (NSCLC).Methods The expression of TFPI-2 and CXCR4 in tumor issues and adjacent normal lung tissues collected from 60 NSCLC patients,and normal tissue collected from 10 healthy subjects were detected by immunohistochemistry.The correlation of the level of CXCR4 and TFPI-2 and the gender,age,histological type,degree of differentiation,lymph node metastasis,TNM stage was analyzed.Results The level of TFPI-2 in tumor tissues was significantly lower than that in carcinoma adjacent tissues and normal tissues,and the level of CXCR4 in the tumor tissue is obvi-ously higher than that in the carcinoma adjacent tissues and normal tissues (P〈0.05 ).There was an correlation of TFPI-2 and CXCR4 level with lymph node metastasis (P〈0.05 ),but this correlation was not seen in the gender, age,histological type,degree of differentiation and TNM staging.The TFPI-2level was negatively correlated with CX-CR4 level in NSCLC (r=0.26,P〈0.05 ).Conclusions TFPI-2 may influence the migration of tumor metastasis through the inhibition of increased CXCR4 expression.
出处 《中国临床保健杂志》 CAS 2014年第3期288-290,共3页 Chinese Journal of Clinical Healthcare
基金 武汉市青年科技晨光计划项目(201050231090)
关键词 非小细胞肺 受体 CXCR4 丝氨酸蛋白酶抑制剂 Carcinoma, non-small-cell lung Receptors, CXCR4 Serine proteinase inhibitors
  • 相关文献

参考文献12

  • 1Scagliotti GV,Selvaggi G.New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer[J].Clin Lung Cancer,2008,9(Suppl 3):122-128.
  • 2Bachelder RE,Wendt MA,Mercurio AM.Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4[J].Cancer Res,2002,62(24):7203-7206.
  • 3Shibuya M,Okamoto H,Nozawa T,et al.Proteomic and transcriotomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2[J].Invest Ophthlmol Vis Sci,2007,48(2):516-521.
  • 4Qin Y,Zhang S,Gong W,et al.Adenovirus-mediated gene transfer of tissue factor pathway inhibitor-2 inhibits gallbladder carcinoma growth in vitro and in vivo[J].Cancer Sci,2012,103(4):723-730.
  • 5Ivanciu L,Gerard RD,Tang H,et al.Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis[J].Arterioscler Thromb Vasc Biol,2007,27(2):310-316.
  • 6laneiu L,Gerard R D,Tang H,et al.Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis[J].Arterioscler Thromb Vase Biol,2007,27(2):310-316.
  • 7Neaud V,Duplantier JG,Mazzocco C,et al.Thrombin UP regulates tissue factor pathway inhibitor-2 synthesis through acyclooxygenase-2 dependent,epidermal growth factor receptorindependent mechanism[J].J Biol Chem,2004,279(7):5200-5206.
  • 8汤志刚,孙振阳,胡何节,许戈良,陈炯,李建生.组织因子途经抑制物2基因在胰腺癌中的表达及对胰腺癌患者预后的影响[J].中华肿瘤杂志,2008,30(8):598-601. 被引量:2
  • 9董永强,纪涛,张晓明,朱水波,徐家行,殷桂林.组织因子途径抑制物-2在非小细胞肺癌中的表达及其与细胞凋亡的关系[J].实用医学杂志,2010,26(11):1903-1905. 被引量:7
  • 10Kondraganti S,Gondi CS,Gujrad M,et al.Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell1ine[J].Int J Oncol,2006,29(1):25-32.

二级参考文献22

  • 1王冬青,纪元,史讯,饶圣祥,叶彤,靳大勇,楼文辉,曾蒙苏.胰腺导管内乳头状黏液肿瘤的CT诊断[J].中华肿瘤杂志,2006,28(8):606-608. 被引量:21
  • 2汪毅,赵平,邵永孚,单毅,王成锋,赵东兵,滕茂芳,田艳涛.胰腺癌术中细针抽吸细胞学的临床应用[J].中华肿瘤杂志,2006,28(10):774-776. 被引量:10
  • 3Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene, 2005, 24:850-858.
  • 4Neaud V, Duplantier JG, Mazzocco C, et al. Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor- independent mechanism. J Biol Chem, 2004, 279:5200-5206.
  • 5Xu Z, Maiti D, Kisiel W, et al. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler Thromb Vasc Biol, 2006, 26:2819-2825.
  • 6Kong D, Ma D, Bai H, et al. Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2. Biochem Biophys Res Commun, 2004, 324 : 1179-1185.
  • 7Rao CN, Reddy P, Reeder DJ, et al. Prokaryotic expression, purification, and reconstitulion of biological activities (antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2. Biochem Biophys Res Commun, 2000, 276: 1286-1294.
  • 8Sun Y, Xie M, Liu M, et al. Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2. Laryngoscope, 2006, 116:596-601.
  • 9Kondraganti S, Gondi CS, Gujrati M, et al. Restoration of tissue factor pathway inhibitor(TFPI) inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int J Oncol, 2006, 29:25-32.
  • 10Rollin J, Iochmann S, Blechet C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer, 2005, 92:775-783.

共引文献7

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部